{
  "docId": "019de073-7e4e-7689-a01c-e0840dac2b61",
  "docSlug": "97e34d6c4db7d9454440fee3efd43545",
  "documentTitle": "Axcella Health | Results Presentation Deck | 62 slides",
  "authorId": "axcella-health",
  "authorName": "Axcella Therapeutics",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-09-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7761332,
  "pageNumber": 27,
  "pageCount": 62,
  "prevPage": 26,
  "nextPage": 28,
  "slideType": "other",
  "function": "analyze_data",
  "density": "dense",
  "nDataPoints": 29,
  "notes": "The slide uses a pathway diagram and a bar chart to demonstrate the mechanism of action of AXA1125 in a Primary Human Hepatocyte (PHH) Lipotoxicity Model.",
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de073-7e4e-7689-a01c-e0840dac2b61/27",
  "deckHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61",
  "deckJsonHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61.json",
  "deckAnchorHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61#slide-27",
  "components": [
    {
      "bbox": {
        "h": 0.65,
        "w": 0.3,
        "x": 0.65,
        "y": 0.22
      },
      "kind": "chart",
      "text": "Beta Oxidation Genes Upregulated by AXA1125",
      "attrs": null,
      "subkind": "bar-horizontal",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7401fab8-71b5-4812-852a-28bceb7f93ff",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.65,
        "w": 0.58,
        "x": 0.03,
        "y": 0.22
      },
      "kind": "diagram",
      "text": "Beta Oxidation Pathway Upregulated by AXA1125",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "67465e60-8dba-45b3-87a9-21e5c70e99de",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.85,
        "x": 0.03,
        "y": 0.9
      },
      "kind": "subtitle",
      "text": "Data derived Primary Human Hepatocyte (PHH) Lipotoxicity Model. Primary Human Hepatocytes were co-treated for 48 hours with 167uM:333uM palmitate:oleate and 1 ng/ml TNF-a to simulate conditions in NASH, 30x LIVRQNAc, RNA was collected in triplicate for RNA-Seq",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b06988c0-5c2f-4f80-991b-702d0e054acf",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.85,
        "x": 0.03,
        "y": 0.03
      },
      "kind": "title",
      "text": "AXA1125 Upregulates Fat Oxidation Genes and Pathway to Increase Consumption of Fatty Acids and Drive Liver Fat Reduction",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2b699783-206d-4b26-89c7-24be6fcdc8b9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.4,
        "x": 0.03,
        "y": 0.13
      },
      "kind": "title",
      "text": "AXA1125 Regulates Mitochondrial Metabolism",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bd05f768-a704-47fd-81d8-dae88221fbb7",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Chart Selection Guide",
      "slug": "chart-selection-guide",
      "agent": "Designer",
      "layer": "slide",
      "matchId": "0c648d8f-5784-412a-a7ff-4ba103b655d0",
      "evidence": "chart/bar-horizontal: Beta Oxidation Genes Upregulated by AXA1125",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [
    {
      "to": 36,
      "from": 6,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "de6af44a-f17d-4c55-adca-ab6e25c41e5d",
      "evidence": "The presentation highlights the need for effective treatment options and the risks associated with disease progression",
      "position": 0,
      "objective": "What is the risk of not treating NASH effectively?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    },
    {
      "to": 30,
      "from": 24,
      "name": "Value Chain Walk",
      "slug": "44-value-chain-walk",
      "bestFor": "Operations improvement, cost reduction, competitive advantage",
      "matchId": "f1102384-67e2-4c89-b8e5-8eb2f1230b26",
      "evidence": "The presentation describes the multi-targeted impact of AXA1125 on NASH disease pathways",
      "position": 1,
      "objective": "How does AXA1125 address the complex disease pathways of NASH?",
      "structure": "Input -> Process Step 1 -> Process Step 2 -> Process Step 3 -> Output -> Value Assessment",
      "confidence": 0.6,
      "description": "Walk through each step of the value chain to identify where value is created or destroyed"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}